Skip to content
healthcare.dev
Get a free key

Doxazosin Mesylate

NDC 53747-352, Doxazosin Mesylate, tablet, from Unichem Laboratories Limited, India.

Product NDC
53747-352
Status
Listed
Labeler
Unichem Laboratories Limited, India
Dosage form
TABLET
Route
ORAL
Product type
HUMAN PRESCRIPTION DRUG
Marketing category
ANDA
Application
ANDA212329
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/53747-352 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • DOXAZOSIN MESYLATE2 mg/1

Pharmacologic classes

Adrenergic alpha-Antagonists [MoA]; alpha-Adrenergic Blocker [EPC]

Package NDCNDC-11Package
53747-352-0153747035201100 TABLET in 1 BOTTLE (53747-352-01)
53747-352-10537470352101000 TABLET in 1 BOTTLE (53747-352-10)
53747-352-135374703521330 TABLET in 1 BOTTLE (53747-352-13)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 53747-352 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/53747-352 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 53747-352. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Get a free keyNDC docsConnect the MCP server

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.